Network Capabilities Built for Sponsor Confidence
Phase I–IV capabilities across multiple Texas sites — from first-in-human through post-marketing. Every capability below maps to what sponsors and CROs evaluate during site selection.
This is a summary of core network capabilities. Our sites are continuously expanding resources and services to meet evolving sponsor and CRO needs. Contact us for a complete site capabilities overview.
Built-In Diversity Across the Network
Diversity of study participants plays an important role. Inclusion of wide patient populations across races, ethnic groups, sex, genders, and ages provides evidence that study products or devices will be safe, effective, and generalizable across the broader target patient pool.
Minority Patient Enrollment
With sites across Houston and Dallas — two of the most racially and ethnically diverse metropolitan areas in the U.S. — our network demographics directly support FDA diversity enrollment guidance and Diversity Action Plan requirements.
Ready to Add a High-Performing Network?
Whether you're a sponsor placing a Phase I–IV study or a CRO looking for reliable, diverse, fast-activating sites across Texas — let's talk.